Regencell Bioscience Holdings Limited (RGC)

Regencell Bioscience Holdings Limited (RGC) is a healthcare company (drug manufacturers - specialty & generic) based in Hong Kong. The share price is $4.55, down 3.60% on the day, which values the company at $2.26B. Price as of 18 Nov 2026, 09:47 UTC, from Yahoo Finance.

Key facts

Share price
$4.55−3.60% today
Market value
$2.26B
200-week average
$6.9635% below
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Regencell Bioscience Holdings Limited in more detail

It sits 35% below its 200-week average of $6.96.

In its favour: More cash than debt. Worth checking: Weak Piotroski score; Debt is growing faster than cash flow.

Regencell Bioscience Holdings Limited (RGC): questions and answers

What is Regencell Bioscience Holdings Limited's market cap?

Regencell Bioscience Holdings Limited is valued at $2.26B at a share price of $4.55.

Is RGC above its 200-week moving average?

No. RGC is 34.6% below its 200-week average of $6.96. Long-term investors watch that line because strong companies rarely trade below it for long.

Does RGC pay a dividend?

Regencell Bioscience Holdings Limited does not currently pay a regular dividend.

Cite this page

Funkfolio, “Regencell Bioscience Holdings Limited (RGC) stock: price, valuation and fundamentals”, data as of 18 November 2026. https://funkfolio.com/stock/RGC

Underlying data: Yahoo Finance; company filings with the SEC.